SEELOS THERAPEUTICS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.33 USD | -2.92% |
|
-30.00% | -88.04% |
| 05-16 | Seelos Therapeutics, Inc. announced that it expects to receive $1.137029 million in funding | CI |
| 05-14 | Seelos Therapeutics to Implement Reverse Stock Split to Regain Bourse Compliance | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SEELOS THERAPEUTICS, INC. | Bio Therapeutic Drugs | -2.92% | -30.00% | -88.04% | -99.40% | -99.79% | 3.47M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- SEEL Stock
- Charts Seelos Therapeutics, Inc.
- Comparison Chart
